Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Sunho Biologics's share price for the quarter that ended in Jun. 2025 was HK$5.26. Sunho Biologics's Shares Outstanding (EOP) for the quarter that ended in Jun. 2025 was 156.67 Mil. Therefore, Sunho Biologics's market cap for the quarter that ended in Jun. 2025 was HK$824.07 Mil.
Sunho Biologics's quarterly market cap
declined
from Jun. 2024 (HK$1,104.50 Mil) to Dec. 2024 (HK$589.07 Mil) but then
increased
from Dec. 2024 (HK$589.07 Mil) to Jun. 2025 (HK$824.07 Mil).
Sunho Biologics's annual market cap
stayed the same
from Dec. 2022 (HK$0.00 Mil) to Dec. 2023 (HK$0.00 Mil) but then
increased
from Dec. 2023 (HK$0.00 Mil) to Dec. 2024 (HK$589.07 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Sunho Biologics's Enterprise Value for Today is HK$604.01 Mil.
Sunho Biologics (HKSE:02898) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Sunho Biologics Market Cap Related Terms
Sunho Biologics Market Cap Historical Data
* Premium members only.
The historical data trend for Sunho Biologics's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02898 vs VRTX, REGN, ALNY: Market Cap Comparison
For the Biotechnology subindustry, Sunho Biologics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sunho Biologics Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Sunho Biologics's Market Cap distribution charts can be found below:
* The bar in red indicates where Sunho Biologics's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Sunho Biologics's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sunho Biologics (HKSE:02898) has a Market Cap of HK$1,001.10 Mil as of Aug. 16, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Sunho Biologics and its competitors.
Is Sunho Biologics' Market Cap too high?
Sunho Biologics' current Market Cap is HK$1,001.10 Mil. Overall, Sunho Biologics has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Sunho Biologics' Market Cap compare to VRTX and REGN?
Sunho Biologics' Market Cap of HK$1,001.10 Mil can be compared against companies in the Biotechnology industry. The industry median Market Cap is 118.89. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 118.89, based on 1,423 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Sunho Biologics and its competitors. For the Biotechnology industry, the median Market Cap is 118.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sunho Biologics's current Market Cap is HK$1,001.10 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunho Biologics stock overvalued right now?
Sunho Biologics (HKSE:02898) has a current Market Cap of HK$1,001.10 Mil. The current Market Cap is HK$1,001.10 Mil. Sunho Biologics' overall GF Score™ is 11/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Sunho Biologics (HKSE:02898), the current Market Cap is HK$1,001.10 Mil as of Aug. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sunho Biologics Inc is a clinical-stage biopharmaceutical company that focuses on the discovery, development and commercialization of biologics for the treatment of cancers and autoimmune diseases. It has three Core Products, IAH0968, IAP0971, and IAE0972, all of which are developed in-house. IAH0968 is an antibody-dependent cell-mediated cytotoxicity (ADCC) enhanced monoclonal antibody (mAb), and the company has initiated Phase II clinical trials for biliary tract carcinoma (BTC) and colorectal cancer (CRC). IAP0971 and IAE0972 are both immunocytokines and It has completed Phase I clinical trials for advanced solid tumors including non-small cell lung cancer (NSCLC) and CRC.
11GF Score
Get the complete analysis for HKSE:02898
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02898 has been successfully added to your 
